SG2014013205A - Formulations of deoxycholic acid and salts thereof - Google Patents

Formulations of deoxycholic acid and salts thereof

Info

Publication number: SG2014013205A
Authority: SG; Singapore
Prior art keywords: formulations; salts; deoxycholic acid; deoxycholic; acid
Prior art date: 2011-08-23

Application number

SG2014013205A

Inventor

Robert Emil Hodge

Jeffrey Douglas Webster

Robert M Moriarty

Original Assignee

Kythera Biopharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-08-23

Filing date

2011-08-23

Publication date

2014-05-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45569726&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG2014013205(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-08-23 Application filed by Kythera Biopharmaceuticals Inc filed Critical Kythera Biopharmaceuticals Inc

2014-05-29 Publication of SG2014013205A publication Critical patent/SG2014013205A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Diabetes (AREA)
Obesity (AREA)
Oil, Petroleum & Natural Gas (AREA)
Inorganic Chemistry (AREA)
Child & Adolescent Psychology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)

SG2014013205A 2011-08-23 2011-08-23 Formulations of deoxycholic acid and salts thereof SG2014013205A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2011/048806 WO2013028177A1 (en)	2011-08-23	2011-08-23	Formulations of deoxycholic acid and salts thereof

Publications (1)

Publication Number	Publication Date
SG2014013205A true SG2014013205A (en)	2014-05-29

Family

ID=45569726

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG2014013205A SG2014013205A (en)	2011-08-23	2011-08-23	Formulations of deoxycholic acid and salts thereof

Country Status (18)

Country	Link
JP (1)	JP5919597B2 (en)
KR (5)	KR102073536B1 (en)
CN (3)	CN108619089A (en)
AU (3)	AU2011375432B2 (en)
BR (1)	BR112014000547B1 (en)
CA (1)	CA2842177C (en)
CR (1)	CR20140053A (en)
EA (1)	EA029305B1 (en)
IL (1)	IL230547A (en)
IN (1)	IN2014CN02188A (en)
MX (1)	MX350390B (en)
MY (1)	MY184277A (en)
NZ (1)	NZ620040A (en)
PH (1)	PH12016501175A1 (en)
SG (1)	SG2014013205A (en)
UA (1)	UA113522C2 (en)
WO (1)	WO2013028177A1 (en)
ZA (1)	ZA201401027B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8101593B2 (en)	2009-03-03	2012-01-24	Kythera Biopharmaceuticals, Inc.	Formulations of deoxycholic acid and salts thereof
KR20180100309A (en) *	2015-11-04	2018-09-10	키쎄라 바이오파마슈티컬즈 인코포레이티드	Methods for the treatment of accumulated fats using deoxycholic acid and its salts
US20180078621A1 (en) *	2016-09-22	2018-03-22	Kyoung Lack Lee	Composition for hypotonic lipolysis and manufacturing method thereof
KR101841193B1 (en) *	2016-09-22	2018-03-22	이경락	Composition for hypotonic lipolysis and manufacturing method thereof
US20190314388A1 (en) *	2018-04-16	2019-10-17	Penmix Ltd.	Pharmaceutical composition containing deoxycholic acid
KR102172439B1 (en) *	2018-12-05	2020-10-30	송미희	Composition for lipolysis and injection composition comprising the same
KR102064864B1 (en)	2019-02-08	2020-01-10	(주)제테마	Topical injectable composition
KR102111346B1 (en) *	2019-08-20	2020-05-22	아영창	Aqueous composition with sodium deoxycholate having improved stability against precipitation
KR20220026068A (en)	2020-08-25	2022-03-04	강명범	Composition for lipolysis and injection composition comprising the same
CN116617160A (en) *	2023-07-25	2023-08-22	山东则正医药技术有限公司	Aqueous suspension, preparation method, freeze-dried powder, application and fat reduction injection
CN118005707A (en) *	2024-01-18	2024-05-10	山东省食品药品检验研究院	Sodium deoxycholate crystal form A and preparation method and application thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2754709B1 (en)	1996-10-23	1999-03-05	Sanofi Sa	COSMETIC COMPOSITION CONTAINING AN ANTAGONIST OF GAMMA NEUROPEPTIDE RECEPTORS AND ALPHA 2 ANTAGONISTS THAT MAY BE INCORPORATED IN SUCH A COMPOSITION
JP4790123B2 (en) *	1998-07-24	2011-10-12	ヨー、セオ、ホン	Dispensing clear aqueous solution with bile acid
US6417179B1 (en)	1998-10-13	2002-07-09	Craig G. Burkhart	Ear wax solution
US20050048126A1 (en) *	2000-12-22	2005-03-03	Barrett Rabinow	Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
DE10361067A1 (en) *	2003-12-22	2005-07-14	Aventis Pharma Deutschland Gmbh	Medicinal lipolysis of fat accumulations
US20060127468A1 (en)	2004-05-19	2006-06-15	Kolodney Michael S	Methods and related compositions for reduction of fat and skin tightening
SI2422789T1 (en) *	2004-05-19	2018-07-31	Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center	Injectable coposition comprising sodium deoxycholate
US7754230B2 (en)	2004-05-19	2010-07-13	The Regents Of The University Of California	Methods and related compositions for reduction of fat
AU2006255097B2 (en)	2005-06-06	2012-02-09	Georgetown University	Compositions and methods for lipo modeling
TW201011755A (en)	2008-09-10	2010-03-16	Skymedi Corp	Flash memory system and its data recovery method
JP5420946B2 (en) *	2009-03-23	2014-02-19	富士フイルム株式会社	Minoxidil aqueous composition containing bile acids
EP2645099A1 (en)	2012-03-30	2013-10-02	Phares Pharmaceutical Research N.V.	Biorelevant compositions

2011
- 2011-08-23 CA CA2842177A patent/CA2842177C/en active Active
- 2011-08-23 CN CN201810400642.9A patent/CN108619089A/en active Pending
- 2011-08-23 MX MX2014001495A patent/MX350390B/en active IP Right Grant
- 2011-08-23 KR KR1020197030233A patent/KR102073536B1/en active IP Right Grant
- 2011-08-23 KR KR1020207002722A patent/KR20200013103A/en not_active Application Discontinuation
- 2011-08-23 JP JP2014527128A patent/JP5919597B2/en active Active
- 2011-08-23 BR BR112014000547-8A patent/BR112014000547B1/en active IP Right Grant
- 2011-08-23 KR KR1020177016779A patent/KR101919269B1/en active IP Right Grant
- 2011-08-23 KR KR1020187032491A patent/KR102034606B1/en active IP Right Grant
- 2011-08-23 MY MYPI2014000197A patent/MY184277A/en unknown
- 2011-08-23 UA UAA201400641A patent/UA113522C2/en unknown
- 2011-08-23 AU AU2011375432A patent/AU2011375432B2/en active Active
- 2011-08-23 NZ NZ620040A patent/NZ620040A/en not_active IP Right Cessation
- 2011-08-23 IN IN2188CHN2014 patent/IN2014CN02188A/en unknown
- 2011-08-23 WO PCT/US2011/048806 patent/WO2013028177A1/en active Application Filing
- 2011-08-23 CN CN201180072842.2A patent/CN103826608A/en active Pending
- 2011-08-23 KR KR1020147006855A patent/KR101751585B1/en active IP Right Review Request
- 2011-08-23 CN CN201810403291.7A patent/CN108743522A/en active Pending
- 2011-08-23 EA EA201490175A patent/EA029305B1/en unknown
- 2011-08-23 SG SG2014013205A patent/SG2014013205A/en unknown
2014
- 2014-01-20 IL IL230547A patent/IL230547A/en active IP Right Grant
- 2014-01-30 CR CR20140053A patent/CR20140053A/en unknown
- 2014-02-10 ZA ZA2014/01027A patent/ZA201401027B/en unknown
2016
- 2016-04-27 AU AU2016202661A patent/AU2016202661B2/en active Active
- 2016-06-16 PH PH12016501175A patent/PH12016501175A1/en unknown
2018
- 2018-04-23 AU AU2018202807A patent/AU2018202807B2/en active Active

Also Published As

Publication number	Publication date
CN108619089A (en)	2018-10-09
AU2011375432B2 (en)	2016-02-04
MX350390B (en)	2017-09-06
KR20170075016A (en)	2017-06-30
KR102034606B1 (en)	2019-10-22
PH12016501175B1 (en)	2017-12-11
KR20190119677A (en)	2019-10-22
CA2842177C (en)	2016-07-19
AU2016202661B2 (en)	2018-02-22
CR20140053A (en)	2014-06-12
JP5919597B2 (en)	2016-05-18
KR101919269B1 (en)	2018-11-15
CN108743522A (en)	2018-11-06
IN2014CN02188A (en)	2015-05-29
AU2018202807A1 (en)	2018-05-10
CN103826608A (en)	2014-05-28
AU2018202807B2 (en)	2020-01-16
BR112014000547A2 (en)	2017-02-14
WO2013028177A1 (en)	2013-02-28
KR20200013103A (en)	2020-02-05
UA113522C2 (en)	2017-02-10
JP2014524467A (en)	2014-09-22
PH12016501175A1 (en)	2017-12-11
MX2014001495A (en)	2014-04-25
MY184277A (en)	2021-03-30
KR101751585B1 (en)	2017-06-27
NZ620040A (en)	2016-06-24
KR20180123734A (en)	2018-11-19
KR102073536B1 (en)	2020-02-04
ZA201401027B (en)	2017-09-27
IL230547A (en)	2017-02-28
AU2011375432A1 (en)	2014-02-06
IL230547A0 (en)	2014-03-31
KR20150000448A (en)	2015-01-02
BR112014000547B1 (en)	2021-11-09
AU2016202661A1 (en)	2016-05-19
EA201490175A1 (en)	2014-06-30
CA2842177A1 (en)	2013-02-28
EA029305B1 (en)	2018-03-30

Publication	Publication Date	Title
ZA201401027B (en)	2017-09-27	Formulations of deoxycholic acid and salts thereof
HK1211295A1 (en)	2016-05-20	C17-heteroaryl derivatives of oleanolic acid and methods of use thereof c17-
ZA201308086B (en)	2015-03-25	Derivatives of 1-anino-2-cyclopropylboronic acid
HK1212355A1 (en)	2016-06-10	C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof c17-
EP2548859A4 (en)	2014-04-02	Preparation methods of methyl-d3-amine and salts thereof
IL236965B (en)	2019-03-31	Derivatives of 5-aminolevulinic acid and uses thereof
EP2619194A4 (en)	2014-09-10	Fatty acid derivatives of catechins and methods of their use
ZA201209666B (en)	2013-07-31	Salts and polymorhs of dexrabeprazole
PT3305298T (en)	2019-07-29	Formulations of deoxycholic acid and salts thereof
PL2702060T3 (en)	2016-06-30	Acid addition salts of risperidone and pharmaceutical compositions thereof
ZA201401599B (en)	2015-08-26	Preparation of methacrylic acid
ZA201207945B (en)	2013-06-26	Salts of dexlansoprazole and their preparation
EP2751071A4 (en)	2015-09-30	Fatty acid amides, compositions and methods of use
EP2782902A4 (en)	2015-08-26	Derivatives of phenoxyisobutyric acid
SG10201607013UA (en)	2016-10-28	Formulations of deoxycholic acid and salts thereof
HUP1100272A2 (en)	2012-01-30	Pharmaceutical use of silicic acid